Otol. Neurotol.
Radiation therapy in cochlear implant recipients.
ABSTRACT
HYPOTHESIS
Processes of scattering and attenuation were investigated to determine the consequence on dose distributions by having a cochlear implant in the field of therapeutic radiation.
BACKGROUND
Radiation oncology medical accelerator beams of 6- and 18-MV x-ray energy were used. Five cochlear implants were investigated.
METHODS
Each implant model was individually studied using computer dose modeling and through exercises in radiation measurement during live delivery.
RESULTS
No side scatter was detected, and negligible backscattering was observed for the primary device housing and electrodes. Attenuation consequences were found to be dependent on the model of cochlear implant studied and specifically dependent on the material composition of each device.
CONCLUSION
The maximum attenuated dose change for the study was found to be -8.8% for 6 MV and -6.6% for 18 MV. This study presents the first comparison of therapeutic radiation delivery versus computerized treatment simulation involving cochlear implants.
Related Questions
Do you have any specific concerns for patients with implanted intracranial devices?
New comment by Radiation Oncologist at University of North Carolina ( July 23, 2019)
Can you address any specific concerns/issues regarding MR image fusion especially in young children with ipsilateral skull base lesions and how you manage those issues, partic...